Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving Endothelial Function with ACE Inhibitors: An Important Therapeutic Target After Coronary Interventions.

Paul C. Keelan1, Abhiram Prasad, Gregory W. Barsness

  • 1Cardiac Catheterization Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. barsness.gregory@mayo.edu

Current Interventional Cardiology Reports
|August 4, 2001
PubMed
Summary

Angiotensin converting enzyme (ACE) inhibitors offer cardiac and vascular protection for patients after coronary revascularization. These drugs improve endothelial function by blocking angiotensin II and increasing nitric oxide availability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraction of Protruding Ostial Stents to Enable Percutaneous Coronary Interventions: The EXPOSE Technique.

JACC. Case reports·2026
Same author

Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis.

Mayo Clinic proceedings·2026
Same author

Erratum to 'Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock' [The American Journal of Cardiology 123(2019) Pages 489-497].

The American journal of cardiology·2026
Same author

Mechanical circulatory support for cardiogenic shock in takotsubo syndrome.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Conservative Acute Management of a Large Paradoxical Coronary Embolism: A Case Report and Systematic Literature Review.

JACC. Case reports·2026
Same author

Percutaneous Management of Cabrol Graft Chronic Total Occlusion: Case Report.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Biology

Background:

  • Adjuvant medical therapy is crucial for patients with coronary artery disease post-percutaneous revascularization.
  • Angiotensin converting enzyme (ACE) inhibitors are considered for their cardioprotective and vasculoprotective properties.
  • The HOPE study provides significant evidence supporting the use of ACE inhibitors in this patient population.

Purpose of the Study:

  • To review the role and mechanisms of ACE inhibitors in post-revascularization coronary artery disease care.
  • To highlight the cellular effects of ACE inhibitors in improving endothelial function.

Main Methods:

  • Literature review focusing on studies investigating ACE inhibitors in coronary artery disease.
  • Analysis of evidence regarding the cellular mechanisms of ACE inhibitors, including effects on angiotensin II and nitric oxide.

Related Experiment Videos

  • Examination of clinical trial data, such as the HOPE study.
  • Main Results:

    • ACE inhibitors demonstrate significant cardiac and vascular protective effects.
    • Evidence supports their efficacy in patients undergoing percutaneous revascularization.
    • Cellular mechanisms involve antagonism of angiotensin II and enhancement of nitric oxide bioavailability.

    Conclusions:

    • ACE inhibitors are a valuable therapeutic option for adjuvant medical therapy in patients with coronary artery disease after percutaneous revascularization.
    • Their favorable effects are mediated at the cellular level, restoring endothelial function.
    • Continued research and clinical application of ACE inhibitors are warranted in this field.